Hotchkis & Wiley Capital Management’s Novartis NVS Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-10,786	Closed	-$896K	–	192
2014 Q4	$896K	Buy	10,786 +21	+0.2%	+$1.74K	﹤0.01%	180
2014 Q3	$908K	Sell	10,765 -714,098	-99%	-$57.8M	﹤0.01%	177
2014 Q2	$58.8M	Sell	724,863 -1,845,236	-72%	-$145M	0.21%	104
2014 Q1	$196M	Buy	2,570,099 +251,918	+11%	+$18.4M	0.73%	42
2013 Q4	$167M	Sell	2,318,181 -54,799	-2%	-$3.81M	0.71%	46
2013 Q3	$163M	Sell	2,372,980 -12,616	-0.5%	-$835K	0.75%	42
2013 Q2	$151M	Buy	+2,385,596	New	+$155M	0.75%	42

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Hotchkis & Wiley Capital Management's NVS Position: Q1 2015 in Review

Hotchkis & Wiley Capital Management sold out of Novartis (NVS) in Q1 2015, closing a stake of 10,786 shares — an estimated $896K sold.

Hotchkis & Wiley Capital Management first reported a position in NVS in Q2 2013 and held it in 7 quarters. The position peaked at $196M in Q1 2014. 940 funds tracked by Wall St. Rank hold NVS as of Q1 2015.

Hotchkis & Wiley Capital Management reported no remaining Novartis position as of Q1 2015 after selling out during the quarter.
Hotchkis & Wiley Capital Management sold 10,786 Novartis shares in Q1 2015, an estimated $896K.
Hotchkis & Wiley Capital Management first reported a position in Novartis in Q2 2013 and held it in 7 quarters.
Hotchkis & Wiley Capital Management's Novartis position peaked at $196M in Q1 2014.
940 funds tracked by Wall St. Rank held Novartis as of Q1 2015.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q1 2015, filed 15 May 2015.